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Abstract 
Muscle mass is an important factor influencing the activity of daily living in older 
adults. We aimed to investigate whether α-actinin-3 (ACTN3) gene R577X 
polymorphism affects muscle mass in older Japanese women. A total of 109 
women (mean ± SD, 64.1 ± 6.0 years) were genotyped for the R/X variant of 
ACTN3. Mid-thigh muscle cross-sectional area (CSA) was assessed using MRI 
and compared using analysis of covariance models adjusted for body weight. In 
addition, physical activity and protein intake were measured as the living 
environmental factors affecting muscle mass. The ACTN3 R577X genotype 
distributions of the subjects were 19, 63 and 27 for the RR, RX, and XX 
genotypes, respectively. No difference in physical activity and protein intake 
were observed among the genotypes. The XX genotype showed lower thigh 
muscle CSA compared with RR&RX genotype (mean ± SEM; XX: 69.1 ± 1.8 cm2, 
RR&RX: 73.6 ± 1.1 cm2; P < 0.05). The results of the present study suggest that 
ACTN3 R577X polymorphism influences muscle mass in older Japanese women.
Introduction 
The actin-binding protein, α-actinin is an important protein related to muscle 
contraction and is a structural component of the Z-lines in skeletal muscle [19, 
24]. The α-actinin isoform, α-actinin-3 (ACTN3) is observed only in type II fibers 
[25, 26]. One billion people are homozygous recessive for α-actinin-3 (ACTN3) 
gene (Chr. 11q13.2) R577X polymorphism (rs1815739), which causes complete 
deficiency of ACTN3 (XX genotype). However, it is not clear how ACTN3 
deficiency affects muscle mass. 
 
  Muscle mass is affected by both genetic and environmental factors. A 
study of postmenopausal women twins showed that the heritability of lean body 
mass is 56% [6]. In addition, living environmental factors such as physical 
activity and protein intake have been identified as important components in 
improving and maintaining muscle mass [8, 16]. Both genetic and living 
environmental factors need to be assessed for preventing age-related loss of 
skeletal muscle mass (sarcopenia). Previous studies have shown that the 
ACTN3 R577X polymorphism is related to muscle strength [9, 30], power [10], 
running ability [22], and athletic performance [27, 33] in Caucasians. Actn3 
knockout (KO) mice used as a model for the human XX genotype showed lower 
lean body mass than wild-type mice [18], suggesting that ACTN3 R577X 
polymorphism affects muscle mass. Although a few studies have shown that 
there is no such linkage in Caucasians [9, 10 and 30], they did not consider 
physical activity and protein intake.  
 
 Sarcopenia, which leads to reduced muscle strength and reduced 
activities of daily living (ADL) [16], affects the lower body with greater frequency 
and severity than the upper body [15], ultimately resulting in reduced walking 
ability and an increased risk of falling [16]. This is an important social issue in 
Japan because 37.7% of the cases where patients are frail and bedridden 
involve sarcopenia. Therefore, prevention of sarcopenia is expected to improve 
the quality of life of older adults. Sarcopenia, which causes selective atrophy of 
type II fibers and disarrangement of Z-lines, affects older people more than 
young people [11]. ACTN3 deficiency in type II fibers might affect sarcopenia. 
This study is based on the hypothesis that older people with ACTN3 deficiency 
have a lower muscle mass than those without it. We investigate the influence of 
the ACTN3 R577X polymorphism on thigh muscle cross-sectional area (CSA) in 
older Japanese women, and examine physical activity and protein intake as 




This cross-sectional study examined 109 healthy Japanese postmenopausal 
women aged 50–78 years (means ± SD, 64.1 ± 6.0 years). The subjects were 
non-smokers who did not have significant cardiovascular, metabolic or 
musculoskeletal disorders. None of the women had taken antidepressant, 
hypolipidemic or hormonal drugs. The study was approved by the Ethical 
Committees of the Institute of Health and Sport Sciences and the Institute of 
Clinical Medicine of the University of Tsukuba. The study conformed to the 
principles outlined in the Declaration of Helsinki. Written informed consent was 
obtained from all subjects before their inclusion in the study. 
 
Genotyping 
The genotype of the ACTN3 R577X polymorphism was identified as described 
previously [23]. Genomic DNA was prepared from EDTA-whole blood samples 
using a kit (QIAamp DNA Blood mini kit; Qiagen. Tokyo, Japan). Genotyping for 
the ACTN3 R577X polymorphism was determined by real-time polymerase 
chain reaction assays using TaqMan probes (Pre-Designed SNP Genotyping 
assays; Applied Biosystems, Tokyo, Japan) and a sequence detector (ABI Prism 
7700; Applied Biosystems, Foster City, CA). The oligonucleotide sequences 
were as follows: 
ACTN3 forward: 5'-ACGATCAGTTCAAGGCAACACT-3' 
ACTN3 reverse: 5'-ACCCTGGATGCCCATGATG-3' 
ACTN3/R probe: 5'-TCGCTCTCGGTCAGC-3' 




Thigh muscle CSA 
Thigh muscle CSA was determined by magnetic resonance imaging (MRI) using 
modified techniques as reported previously [5]. Each subject’s right foot was 
visualised by MRI (0.25 Tesla, AIRIS Mate; Hitachi Medical, Tokyo, Japan). All 
the cross-sectional MRI scans were obtained using a conventional T1-weighted 
spin-echo sequence (28 ms echo time, 360 ms repetition time), with a 10 mm 
slice thickness, a 20 mm intersection interval, a 240 mm field of view, 256 × 180 
matrix, 90° flip angle and 4 signals on an average. The MRI images were then 
analysed by manual planimetry using a hand-writable liquid crystal display 
(Cintiq 17SX; WACOM, Tokyo, Japan) and image analysis software (NIH Image 
ver. 1.62; National Institute of Health, USA) on a personal computer (Macintosh 
Power PC; Apple, Tokyo, Japan). The DICOM image data from MRI were 
converted into 652 × 652 pixels JPEG picture images. The MRI scans were 
assessed in a blind manner, i.e. the identity of the subject was not revealed. The 
cross-sectional MRI corresponding to the area between the greater trochanter 
and medial condyle of the femur was analysed. The regions of thigh muscle CSA 
included quadriceps femoris, hamstrings and adductor magnus muscles. Thigh 
muscle CSA was measured from the mean value of three traces. 
 
Measurement of daily physical activity 
Daily physical activity was measured using a uniaxial accelerometer 
(Life-Corder; Suzuken, Nagoya, Japan) as described in a previous study [14]. All 
subjects wore the accelerometer on their waist continuously for 14 days, except 
during sleeping and bathing. The total physical energy expenditure (kcal) was 
calculated from the energy measured by the accelerometer combined with a 
questionnaire based on the Compendium of Physical Activity [4], which was 
administrered to all subjects.  
 
Measurements of blood components 
The blood components were measured as described in a previous study [14]. 
Subjects were instructed to abstain from vigorous exercise and fast on the day 
prior to the measurements. Plasma glucose concentrations and fasting serum 
concentrations of cholesterol, triglycerides and insulin were determined using 
standard enzymatic techniques. The homeostasis model for assessing insulin 
resistance (HOMA-IR) was calculated using the formula fasting plasma insulin 
(µU/ml) × fasting plasma glucose (mg/dl)/405 [21]. 
 
Measurement of dietary intake 
A nutritionist assessed each subject’s daily nutritional intake of carbohydrates, 
fat, protein and calories by conducting a 3-day survey of food intake. 
 
Statistical analysis 
Statistical analyses were performed using SPSS Base System 14.0 J for 
Windows (SPSS Japan, Tokyo, Japan) and R (Ver. 2.6.0) [2]. The ACTN3 
R577X genotype distribution was evaluated for conformity with the 
Hardy-Weinberg equilibrium using the χ2 test with one degree of freedom. 
Differences in physical characteristics between XX, RR and RX genotypes were 
tested using analysis of variance (ANOVA), and between the XX and RR&RX 
genotypes using unpaired t-tests. Thigh muscle CSA was compared between 
the genotype groups using an analysis of covariance (ANCOVA) model with age, 
height, body weight, physical activity, and protein intake as covariates. Linear 
regression analysis, including likelihood ratio tests between full (genotype and 
body weight) and constrained (only body weight) models, were performed to 
estimate the degree of variance in thigh muscle CSA attributable to the ACTN3 




Table 1 shows the ACTN3 R577X genotype distributions of the subject 
population. The genotype frequencies are in Hardy-Weinberg equilibrium (χ2 
value = 2.87, df = 1, P = 0.09). No significant differences were found for age, 
height, body weight, body mass index (BMI), physical activity, daily nutritional 
intake, blood parameters or HOMA-IR among the ACTN3 R577X genotypes (RR 
vs. RX vs. XX using ANOVA), or among cases with and without ACTN3 (RR&RX 
vs. XX using t-test) (Table 2).  
 
 As described in a previous study [9], we assessed all factors that were 
considered to be covariates that influence thigh muscle CSA. Body weight was 
found to have a significant influence, while age, height, physical activity and 
protein intake did not. We therefore statistically adjusted thigh muscle CSA with 
body weight as a covariate. This showed that the thigh muscle CSA of the 
subjects was significantly lower in the XX genotype than in the RR&RX genotype 
(Table 2). Table 3 shows that the ACTN3 R577X genotypes accounted for 3.3% 
of the variability in thigh muscle CSA. 
 
Discussion 
The results of this study show that there is a relationship between thigh muscle 
CSA and the ACTN3 R577X polymorphism in older Japanese women. The XX 
genotype with ACTN3 deficiency shows a smaller muscle CSA than the RR&RX 
genotype in which ACTN3 is present. These differences appear to be influenced 
more by genetic factors than by living environmental factors such as daily 
physical activity and nutritional intake.  
 
 This study suggests the possibility that ACTN3 R577X polymorphism 
influences thigh muscle size, although the underlying mechanisms are not 
known. It has been reported that Actn3 KO mice simulating human XX genotype 
have lower lean mass than wild-type mice [18]. In addition, Walsh et al. recently 
reported that the absence of ACTN3 affects fat-free mass in women but not in 
men [31]. However, CSA and the muscle fiber area of the quadriceps muscle in 
younger people shows no differences among the ACTN3 R577X genotypes [30]. 
We assume that ACTN3 R577X genotypes affect the acuteness of sarcopenia. 
A recent study showed that this polymorphism is significantly associated with the 
age-related changes in the human phenotype [28]. That is, it influences the 
phenotypes of older adults but not young people. Future studies should 
investigate the extent to which the ACTN3 R577X polymorphism affects the 
alteration in muscle mass with aging and the mechanisms by which ACTN3 
deficiency influences muscle mass.  
 
ACTN3 is expressed only in type II fibers, particularly type II b fibers. A 
deficiency of ACTN3 therefore changes the characteristics of type II b fibers. For 
example, Actn3 KO mice simulating the human XX genotype have lower lean 
mass than wild-type mice because KO mice have a smaller type II b fiber 
diameter [18]. In humans, the XX genotype has fewer type II x (also called type II 
b/x) fibers than the RR genotype [30]. Because type II fibers are related to 
sarcopenia and ACTN3, the XX genotype may show a decrease in type II b 
fibers with aging. Further investigation of changes in characteristics of 
ACTN3-deficient muscle fiber characteristics with aging is needed. 
 
 ACTN3 deficiency may affect the muscle size through the survival motor 
neuron 1 (SMN1) pathway in skeletal muscles. Recently, the human SMN1 gene, 
which is responsible for spinal muscle atrophy (SMA), was reported to interact 
with α-actinin in Z-lines [29]. In fact, SMA causes remarkably more atrophy in the 
trunk and lower body than in the upper body, and frequently, selective atrophy of 
type II fibers [7]. These features resemble sarcopenia. It is therefore possible 
that the interaction of ACTN3 with SMN1 causes selective atrophy of type II 
fibers in sarcopenia observed in older adults. We are also interested in the 
calcineurine pathway discussed by Vincent et al. [30]. These molecular changes 
observed in cases of sarcopenia with ACTN3 deficiency should be investigated 
further in future. 
 
 ACTN3 anchors actin filaments to the Z-disk and incorporates the 
contractile properties of actomyosin. However, 22–25% of Asian people have an 
ACTN3-deficient XX genotype [3]. The results presented here (24.7%) are in 
agreement with this number. In addition, the subjects’ characteristics are 
representative of the mean height and body weight of the general population of 
middle-aged and older Japanese women [1]; the mean BMI was categorised as 
normal weight. Moreover, the subjects had typical physical activity and daily 
nutritional intake, along with normal blood parameters. They had no history of 
cardiovascular, metabolic or musculoskeletal disorders. Therefore, the subjects 
were regarded as healthy, making the present findings applicable to general 
population.  
 We found that the variability attributable to the ACTN3 R577X genotype 
was 3.3% for thigh muscle CSA in older Japanese women. The result is similar 
to Clarkson’s observation that the ACTN3 R577X genotype explained 2.2% of 
the baseline arm muscle strength in young women. Recently, three studies have 
investigated the relationship between height and gene polymorphism indicating 
12-27 SNP explained 2.0-3.7 % of human height [13, 17, 32]. Therefore, one 
SNP contribution is not likely to have a high impact on morphology. 
 
 There are some limitations to the current investigation. Although, this 
study indicates that the XX genotype results in a significantly smaller thigh 
muscle CSA compared to the RR&RX genotype, the study was performed on a 
small sample size. In addition, thigh muscle size was not evaluated as muscle 
volume. However, for lower limbs, the middle muscle CSA is commonly used to 
indicate the muscle size of the thigh [5, 20]. Previous studies have indicated that 
thigh muscle CSA measured from a single MR image provides a good indication 
of muscle volume [20]. Another limitation was that this study only considered 
older women. Previous studies have reported that the ACTN3 R577X 
polymorphism influences fat-free mass [31], muscle strength [9], and athletic 
performance [32] in women but not men. However, sarcopenia affects both 
sexes. Therefore, future studies should include Japanese men. 
 
 In conclusion, the interaction of genetic and living environmental factors 
affects the human muscle phenotype. The subjects examined in this study were 
typical middle-aged or older Japanese women who were healthy and of normal 
weight. The genotype groups examined showed many similar characteristics; 
however, the XX genotype showed markedly lower thigh muscle CSA than the 
RR&RX genotype. The results show that ACTN3 R577X polymorphism 
influences the size of the thigh muscles of older women. Our data suggests that 
ACTN3 deficiency might affect the muscle mass in older adults. 
The ACTN3 R577X polymorphism is an important consideration for future 
studies aiming to determine how muscle mass can be preserved in older people.  
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Table 1  ACTN3 R577X genotype distributions of the subject population 
          Allele 
 Genotype  Frequency 
  RR RX XX   R X 
All subjects             
(n = 109) 19 (17.4%) 63 (57.8%) 27 (24.8%)   0.463  0.537  
 
 
 Table 2  Characteristics of the subject by ACTN3 R577X genotype 
  RR  RX  XX   RR&RX  P Value 





  (n = 19)  (n = 63)  (n = 27)   (n = 82)  
Age (years old) 64.1 (1.3)  63.8 (0.8)  64.9 (1.1)  63.9 (0.7)   0.76 0.47 
Height (cm) 151.2 (1.5)  151.2 (0.7)  150.3 (0.9)  151.2 (0.7)  0.76 0.46 
Body Weight (kg) 52.5 (1.7)  53.0 (0.8)  53.3 (1.2)  52.9 (0.7)  0.93 0.79 
BMI (kg/m2) 22.9 (0.6)  23.2 (0.3)  23.6 (0.5)  23.1 (0.3)  0.71 0.45 
Thigh muscle CSA (cm2) † 75.2 (2.2)  73.0 (1.2)  69.1 (1.8)  73.6 (1.1)  0.07 0.04 
Physical Activity (kcal/day) 178.9 (15.4)  178.2 (10.6)  163.2 (16.6)  178.4 (8.9)  0.71 0.41 
Daily Nutritional Intake           
   Total caloric Intake (kcal/day) 2013 (74)  2057 (59)  2047 (76)  2047 (48)  0.92 1.00 
   Carbohydrate Intake (g/day) 303.9 (12.7)  306.3 (11)  308.3 (14.4)  305.8 (8.9)  0.98 0.89 
   Fat Intake (g/day) 52.9 (3.5)  53.8 (2.1)  53.5 (3.0)  53.6 (1.8)  0.98 0.99 
   Protein Intake (g/day) 79.4 (3.5)  81.6 (2.1)  78.9 (2.7)  81.1 (1.8)  0.73 0.54 
Blood parameters           
   Total Cho (mg/dl) 218.2 (7.8)  217.5 (4.4)  224.7 (6.7)  217.7 (3.8)  0.66 0.36 
   LDL-Cho (mg/dl) 128.1 (6.9)  132.5 (3.6)  139.1 (5.8)  131.5 (3.2)  0.43 0.24 
   HDL-Cho (mg/dl) 59.4 (3.0)  60.7 (1.5)  60.6 (2.9)  60.4 (1.3)  0.92 0.93 
   Triglycerides (mg/dl) 109.4 (17.2)  101.7 (6.1)  98.8 (7.5)  103.5 (6.1)  0.78 0.68 
   Insulin (μU/ml) 5.3 (0.6)  6.8 (0.7)  9.3 (3.4)  6.5 (0.5)  0.35 0.42 
   Glucose (mg/dl) 97.1 (1.7)  96.7 (1.0)  105.1 (5.7)  96.8 (0.8)  0.07 0.16 
   HOMA-IR 1.29 (0.17)   1.69 (0.20)   2.37 (0.80)   1.59 (0.16)   0.28 0.35 
Values are mean (SEM). †Adjusted for body weight by ANCOVA. BMI, Body mass index; CSA, Cross-sectional area; Cho, Cholesterol; 
LDL, low density lipoprotein; HDL, High density lipoprotein; HOMA-IR, Homeostasis model assessment of insulin resistance. 
Table 3   Variablity in thigh muscle cross-sectional area of subjects attributable to ACTN3 R577X genotype. 
Measurement r2 Full model 
r2 Constrained 
Model 
Variability Attributable to Likelihood Ratio 
Genotype Effect Test P Value† 
Thigh muscle CSA 0.219 0.186 3.3% 0.037 
†Likelihood ratio test comparing full model (with genotype and body weight) to constrained model (body weight only). CSA, 
Cross-sectional area. 
 
